Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: [insulin Pump Therapy In Patients With Type 1 Diabetes].
Author: Minicucci, Walter José
Abstract: Both Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injections (MDI) are effective ways of implementing intensive management of DM1 to attain near normal glycemic levels and a more flexible lifestyle. CSII is as safe as MDI and has some advantages over it mostly in diabetic patients with frequent hypoglycemias with important dawn phenomenum, gastroparesia, during pregnancy, in children and in patients with an erratic way of living. CSII allows a better chance to reach better glycemic control with less hypoglycemia, asymptomatic hypoglycemias and a better quality of life. Besides, risks are lower and adverse events are less frequent in DM1 patients under CSII as compared to MDI. To obtain results like this, a careful adjustment of basal and boluses insulin doses and an adequate patient follow-up are essential.
Subject: Adult
Blood Glucose
Controlled Clinical Trials As Topic
Diabetes Mellitus, Type 1
Dietary Carbohydrates
Drug Administration Schedule
Hypoglycemic Agents
Infusions, Subcutaneous
Injections, Subcutaneous
Insulin Infusion Systems
Patient Selection
Quality Of Life
Treatment Outcome
Young Adult
Rights: aberto
Identifier DOI: 
Date Issue: 2008
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_18438545.pdf141.52 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.